Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Common Equity (2020 - 2025)

Historic Common Equity for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • iSpecimen's Common Equity fell 3482.52% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 3482.52%. This contributed to the annual value of $3.3 million for FY2024, which is 6600.98% down from last year.
  • As of Q3 2025, iSpecimen's Common Equity stood at $3.1 million, which was down 3482.52% from $621973.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Common Equity ranged from a high of $29.8 million in Q4 2021 and a low of $621973.0 during Q2 2025
  • For the 5-year period, iSpecimen's Common Equity averaged around $12.8 million, with its median value being $11.4 million (2021).
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 20921.48% in 2021, then plummeted by 8978.58% in 2025.
  • iSpecimen's Common Equity (Quarter) stood at $29.8 million in 2021, then plummeted by 31.83% to $20.3 million in 2022, then tumbled by 52.04% to $9.7 million in 2023, then plummeted by 66.01% to $3.3 million in 2024, then decreased by 7.2% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $621973.0 for Q2 2025, and $1.7 million during Q1 2025.